Eversheds Sutherland - Legal Insights Eversheds Sutherland

Tune in to our inaugural episode of our new podcast series on Private Equity trends in Europe. Partners Matthew Allen and James Trevis discuss our Private Equity team's recent win at the Real Deals Private Equity Awards, highlight some recent key deals we have advised on, and what the future holds for the team.

In the ninth episode in this series, we are joined by John Pruitt in New York and Martin Mankabady in London for a discussion on AI use cases and regulation in the insurance industry.

In our eighth episode we are joined by Ann Fort (US Intellectual Property Partner) and David Wilkinson (UK Company Commercial Partner) for a discussion on Intellectual Property and Anti-Trust. Designed to help you look beyond the headlines and hype cycle, this series will help you make the most of the significant opportunity AI brings on an informed basis, taking into account the rapidly evolving legal, regulatory and risk and control frameworks in which the financial services industry operates.

Utilizing health data requires health and life sciences companies to tread a fine line between innovation and protecting patient privacy. Listen to the latest episode in our Data as an Asset podcast series, where we outline: key US, EU and UK regulations global health and life sciences companies need to be aware of,  the obstacles and opportunities for research, product development, patients and the public good and AI's potential for healthcare innovation

Having first been introduced in the House of Commons 13 months ago, the UK Digital Markets, Competition and Consumers (#DMCC) Act received Royal Assent today. In this podcast, Julia Woodward-Carlton and Annabel Borg explain how the new regime will proceed and what businesses need to do to comply.

Listen to this podcast highlighting a surge in 2024 mergers and acquisitions in the UK's challenger bank sector, contrasting with 2023's low activity. Paul Pugh, Timothy Fosh, Shelley Evans and Emma Jones discuss the profitability challenges of challenger banks, the complexities of deal structures, regulatory issues, and integration hurdles, suggesting mergers might often be more effective than acquisitions.